Humanized 3F8 Monoclonal Antibody (Hu3F8) in Patients With High-Risk Neuroblastoma and GD2-Positive Tumors
Clinical trial NCT01419834 · COMPLETED
Trial details
- NCT number
- NCT01419834
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-15
- Primary completion
- 2023-08-02
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.